Status:
RECRUITING
Interventional Study on Smoking Reduction in Psychiatry
Lead Sponsor:
GCS-CCOMS
Collaborating Sponsors:
INSERM ECEVE 1123
Conditions:
Tobacco Addiction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The smoking rate among people with mental disorders is higher than in the general population. Greater exposure to the harmful effects of tobacco partly explains the major inequality in life expectancy...
Detailed Description
The smoking rate among people with mental disorders is higher than in the general population. Greater exposure to the harmful effects of tobacco partly explains the major inequality in life expectancy...
Eligibility Criteria
Inclusion
- Regular smokers (at least one cigarette per day)
- Followed in psychiatric ambulatory care at one of the participating sectors' CMPs
- Adults (18 years or older)
- Covered by the statuary health insurance
- Who gave their informed consent to participate to the study
Exclusion
- Users under guardianship or legal protection,
- Psychological state incompatible with completing the questionnaire,
- Persons with no command or understanding of the French language
Key Trial Info
Start Date :
January 15 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 14 2026
Estimated Enrollment :
6500 Patients enrolled
Trial Details
Trial ID
NCT06926153
Start Date
January 15 2025
End Date
July 14 2026
Last Update
June 6 2025
Active Locations (22)
Enter a location and click search to find clinical trials sorted by distance.
1
Public mental health establishment of Lille Metropole (59G16-G17)
Armentières, France, 59280
2
Public mental health establishment of Lille Metropole (59G21)
Armentières, France, 59280
3
Flanders public mental health establishment (59G05/06)
Bailleul, France, 59270
4
Barthelemy Durand public health establishment (91G05)
Étampes, France, 91150